AstraZeneca Buys Rare Disease Drug Maker

🇬🇧 🇬🇧 AstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal. Caelum’s drug candidate aims to treat AL amyloidosis, a rare, life-threatening disease
HumanQuant By HumanPotential – A Bespoke Algo Driven Investment Program Powered By 75% A.I. and 25% Human Intelligence
From A Blank Canvas, We Create Wealth With 90% Accuracy, Trading Equities, ETFs, Futures, FX and Cryptos. Risk Versus Reward Is Crafted To Suit Your Requirements
Talk To Us Today And Let Us Give You A Taste Of The Great Disruption: bit.ly/AlgoTrader OR bit.ly/AlgoFactory
AlgorithmicInvestment #AccuracyProfits #HumanQuant #AZN

Leave a comment